Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2005
12/20/2005US6977161 Solid support assay systems and methods utilizing non-standard bases
12/20/2005US6977158 Mammalian IAP gene family, primers, probes, and detection methods
12/20/2005US6977156 Flow cytometry reagent and system
12/20/2005US6977155 Arrays of biological membranes and methods and use thereof
12/20/2005US6977147 Method of screening therapeutic or preventative agents for squamous epithelial cell carcinoma
12/20/2005US6977145 Method for carrying out a biochemical protocol in continuous flow in a microreactor
12/20/2005US6977144 Nucleic acids encoding Selected Interacting Domain (SID registered) polypeptides binding selectively to a peptide encoded by a pathogenic strain of the hepatitis C virus; genetic engineering; gene therapy; bactericides;
12/20/2005US6977143 optional purifcation by chromatography prior to ionization and analysis; high turbulance liquid chromatography (HTLC)
12/20/2005US6977141 Direct adsorption scintillation assay for measuring enzyme activity and assaying biochemical processes
12/20/2005US6977078 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
12/20/2005US6977071 Use for treatment of inflammatory diseases, HIV-infection, angiogenisis and hematopoiesis-related disorders;
12/20/2005US6977068 administering a colloid of a detectable marker encased in carbon; detecting the presence of the diagnostic particles binding to fibrin;
12/20/2005US6977032 Biosensor
12/20/2005US6976398 Liquid sample collection system
12/20/2005US6976383 Apparatus for high temperature withdrawal or dispensing of fluids
12/20/2005CA2385830C Probe for protein-protein interaction analysis, and method of using it for analysis of protein-protein interaction
12/20/2005CA2343000C Method for making insertional mutations
12/20/2005CA2339224C Method for detecting drugs, and a solvent and a decomposition solution used therefor
12/20/2005CA2336153C Method for early diagnosis of carcinomas
12/20/2005CA2321610C C-myc coding region determinant-binding protein (crd-bp)
12/20/2005CA2303761C A method of determining peptide sequences by mass spectrometry
12/20/2005CA2266319C Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
12/20/2005CA2242197C Total protein detection method
12/20/2005CA2235316C A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
12/20/2005CA2194184C Determining biodegradability of aspartic acid derivatives, degradable chelants, uses and compositions thereof
12/20/2005CA2120481C Assay system
12/20/2005CA2052883C Pledget compositions and process for making same
12/18/2005CA2509049A1 Production of mutant strain of aspergillus fumigatus, method and assay for inhibiting siderophore biosynthesis and diagnostic method for detecting likely aspergillus fumigatus infection
12/16/2005CA2508583A1 Device for performing measurements and/or taking samples in molten metals
12/15/2005WO2005119564A2 Method for the use of density maps based on marker values in order to diagnose patients with diseases, particularly tumors
12/15/2005WO2005119285A1 Process for the determination of lipoproteins in body fluids
12/15/2005WO2005119267A1 Assay system with in situ formation of diazo reagent
12/15/2005WO2005119266A1 Sr-a antagonists
12/15/2005WO2005119265A1 Protein detection
12/15/2005WO2005119264A1 Method for screening and compositions for treating cancers
12/15/2005WO2005119263A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 92 (gpr92)
12/15/2005WO2005119262A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/15/2005WO2005119261A2 Glut5 transporters expressed in cancer cells
12/15/2005WO2005119260A2 Methods for predicting and monitoring response to cancer therapy
12/15/2005WO2005119259A2 Population based prediction methods for immune response determinations and methods for verifying immunological response data
12/15/2005WO2005119258A1 Method of simultaneously assaying plural number of substances and assay device to be used therein
12/15/2005WO2005119257A1 Process and kit for determining binding parameters of bioaffinity binding reactions
12/15/2005WO2005119256A1 Method of quickly detecting and/or assaying antigen by fluorescence correlation spectrometry
12/15/2005WO2005119255A2 Constrained cis-diol-borate bioconjugation system
12/15/2005WO2005119254A1 Luminescent compounds having a functionalised linker arm used in the bioconjugation and labelling of biomolecules
12/15/2005WO2005119253A1 Diagnostic testing process and apparatus incorporating controlled sample flow
12/15/2005WO2005119252A2 Modulators of gpr35 for the treatment of metabolic-related disorders
12/15/2005WO2005119251A2 Novel means and methods for the treatment of hearing loss and phantom hearing
12/15/2005WO2005119250A1 New intravenous drug administration and blood sampling model in the awake rat
12/15/2005WO2005119249A2 Reagents for arsenic meter
12/15/2005WO2005119248A1 Calibration device for gas sensors
12/15/2005WO2005119247A1 A sensing door handle
12/15/2005WO2005119246A2 NOx GAS SENSOR METHOD AND DEVICE
12/15/2005WO2005119244A1 Peptide modulators of cellular phenotype and bi-nucleic acid fragment library
12/15/2005WO2005119234A2 Measuring device and methods for use therewith
12/15/2005WO2005119233A1 Stress sensor with capture coating for detecting a target substance
12/15/2005WO2005119230A2 Pharmacophores for nociceptin, methods of obtaining and using in screening for nociceptin mimics
12/15/2005WO2005119211A1 Device for collecting blood and separating blood constituents, method for separating blood constituents and use of said device
12/15/2005WO2005119207A1 Analyte accumulation device
12/15/2005WO2005119201A1 Method and device for rapid detection and quantitation of macro and micro matrices
12/15/2005WO2005119034A1 Method of determining cetane number of fuel in internal combustion engine
12/15/2005WO2005118885A2 Methods and apparatus for detection of viral infection
12/15/2005WO2005118884A1 A method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
12/15/2005WO2005118878A2 Methods of screening for cell proliferation or neoplastic disorders
12/15/2005WO2005118876A2 Egfr mutations
12/15/2005WO2005118875A2 Diagnosing or predicting the course of breast cancer
12/15/2005WO2005118858A1 Multigene predictors of response to chemotherapy
12/15/2005WO2005118843A1 Compositions and methods
12/15/2005WO2005118842A1 Method for measuring enzyme activity and column for use in measuring enzyme activity
12/15/2005WO2005118841A1 Assay of ubiquitinization of synoviolin and use thereof in screening
12/15/2005WO2005118840A2 Diagnostics and therapeutics for diseases associated with kallikrein 10 (klk10)
12/15/2005WO2005118834A2 Methods for identifying risk of breast cancer and treatment thereof
12/15/2005WO2005118833A2 Diagnostics and therapeutics for diseases associated with sterile-alpha motif and leucine zipper containing kinase (zak)
12/15/2005WO2005118817A1 Method for high speed screening for the identification of molecules inhibiting the activity of editing enzymes
12/15/2005WO2005118813A2 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein
12/15/2005WO2005118811A1 Novel polypeptide useful for diagnosis and treatment of cancer
12/15/2005WO2005118804A1 Method of specifically detecting bacterium belonging to the genus alicyclobacillus
12/15/2005WO2005118787A2 Method of screening candidate compounds for susceptibility to biliary excretion
12/15/2005WO2005118783A1 Prognostic tests for development of dermal stretch marks and implications for the preventive treatment thereof
12/15/2005WO2005118645A1 Antibody specific for a chondroitin sulphate epitope
12/15/2005WO2005118644A2 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005WO2005118631A1 Novel protein complex and use thereof
12/15/2005WO2005118629A1 BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS
12/15/2005WO2005118626A2 Peptides for inducing a ctl and/or htl response to hepatitis c virus
12/15/2005WO2005118622A2 Naturally processed measles virus peptides eluted from class ii hla molecules
12/15/2005WO2005118615A1 Inhibitors of regiii proteins as asthma therapeutics
12/15/2005WO2005118139A1 Controlled flow assay device and method
12/15/2005WO2005117998A2 Smvt transporters expressed in cancer cells
12/15/2005WO2005117996A2 Immune response assessment method
12/15/2005WO2005117994A2 Bmp pathway methods and compositions
12/15/2005WO2005117986A2 Antibody drug conjugates and methods
12/15/2005WO2005117979A2 Use of il-17 in the treatment of fertility-related disorders
12/15/2005WO2005117952A2 Treatment methods utilizing albumin-binding proteins as targets
12/15/2005WO2005117950A2 Regulation of glucose and insulin levels by gnt-4 glycosyltransferase activity
12/15/2005WO2005117936A2 Method for enhancing or inhibiting insulin-like growth factor-i
12/15/2005WO2005117931A2 Glut1 transporters expressed in cancer cells
12/15/2005WO2005117930A2 Use of thioredoxin measurements for diagnostics and treatments
12/15/2005WO2005117906A1 Combination for inhibiting bone resorption comprising a bisphosponate (alendrona) and a vitamin d (cholecalciferol)
12/15/2005WO2005117897A2 Hepoxilins and modulators of ichthyin for treatment skin disorders
12/15/2005WO2005117617A1 Index and method of use of adapted food compositions for dysphagic persons
1 ... 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 ... 3937